high throughput molecular dynamics
high-throughput molecular dynamics
HTMD platform
high-throughput MD
computational platform
simulation throughput
cloud application platform
high barrier
Acellera
cloud environment
approved drug
HTMD solution
rational drug design
disruptive computational technology
high degree of unnecessary technical complexity
development of technology
proprietary simulation technology
rational drug discovery workflows
drug candidate identification
cost of pre-clinical research
market viability
Phase
research productivity
feasibility study
silico computational methods
useful description of molecular interactions
subsequent market launch
operational environment
pharmaceutical companies
Feasibility assessment
better drugs
methods available
unprecedented degree of resolution
pharmaceutical industryâ€™s increasing spending
PCR
novel resource
prototyping
speed
user-friendly interfaces
accuracy
progress
pace
preparations
larger-scale demonstration
current state
execution
SME Instrument
Euro
understanding
art
traction
entry
issues
biological targets
TRL
global leader
simulations
key steps
factors
competitiveness
Results